Free Trial

Feedback (FDBK) Competitors

Feedback logo
GBX 14.35 +0.35 (+2.50%)
As of 05:49 AM Eastern

FDBK vs. COG, INHC, TRLS, IQAI, DVRG, SENS, EMIS, CRW, INS, and KOO

Should you be buying Feedback stock or one of its competitors? The main competitors of Feedback include Cambridge Cognition (COG), Induction Healthcare Group (INHC), Trellus Health (TRLS), IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), and Kooth (KOO). These companies are all part of the "health information services" industry.

Feedback vs.

Cambridge Cognition (LON:COG) and Feedback (LON:FDBK) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends, valuation, community ranking and media sentiment.

In the previous week, Cambridge Cognition's average media sentiment score of 0.00 equaled Feedback'saverage media sentiment score.

Company Overall Sentiment
Cambridge Cognition Neutral
Feedback Neutral

Feedback received 60 more outperform votes than Cambridge Cognition when rated by MarketBeat users. Likewise, 67.07% of users gave Feedback an outperform vote while only 44.30% of users gave Cambridge Cognition an outperform vote.

CompanyUnderperformOutperform
Cambridge CognitionOutperform Votes
105
44.30%
Underperform Votes
132
55.70%
FeedbackOutperform Votes
165
67.07%
Underperform Votes
81
32.93%

Cambridge Cognition has a net margin of -10.07% compared to Feedback's net margin of -279.16%. Feedback's return on equity of -39.71% beat Cambridge Cognition's return on equity.

Company Net Margins Return on Equity Return on Assets
Cambridge Cognition-10.07% -68.83% -0.30%
Feedback -279.16%-39.71%-22.99%

35.2% of Cambridge Cognition shares are owned by institutional investors. Comparatively, 53.2% of Feedback shares are owned by institutional investors. 29.9% of Cambridge Cognition shares are owned by company insiders. Comparatively, 10.8% of Feedback shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Cambridge Cognition has higher revenue and earnings than Feedback. Cambridge Cognition is trading at a lower price-to-earnings ratio than Feedback, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cambridge Cognition£15.64M0.96-£1.58M-£3.76-9.49
Feedback£3.88M1.56-£10.84M-£24.74-0.56

Cambridge Cognition has a beta of 0.72, meaning that its share price is 28% less volatile than the S&P 500. Comparatively, Feedback has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500.

Summary

Feedback beats Cambridge Cognition on 7 of the 13 factors compared between the two stocks.

Get Feedback News Delivered to You Automatically

Sign up to receive the latest news and ratings for FDBK and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FDBK vs. The Competition

MetricFeedbackHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£6.05M£204.68M£5.57B£2.56B
Dividend Yield4.56%6.68%5.11%4.84%
P/E Ratio-0.56219.8722.44132.42
Price / Sales1.56471.47394.09240,284.87
Price / Cash1.1247.1438.1828.16
Price / Book0.245.196.774.55
Net Income-£10.84M-£15.55M£3.22B£5.85B
7 Day Performance-19.24%0.94%1.49%2.57%
1 Month Performance-18.04%0.59%4.00%8.70%
1 Year Performance-83.26%8.99%16.21%113.17%

Feedback Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FDBK
Feedback
N/AGBX 14.35
+2.5%
N/A-84.7%£6.29M£3.88M-0.5824
COG
Cambridge Cognition
N/AGBX 35.80
-0.6%
N/A-30.7%£14.99M£15.64M-9.5180Earnings Report
INHC
Induction Healthcare Group
N/AGBX 9.60
+1.1%
N/A-26.8%£8.86M£12.57M-1.7374Positive News
High Trading Volume
TRLS
Trellus Health
N/AGBX 1.61
-5.3%
N/A+11.1%£3.11M£65,831.01-0.4731Gap Down
IQAI
IQ-AI
N/AGBX 0.81
-2.9%
N/A-40.9%£1.80M£538,190.00-13.676Earnings Report
News Coverage
Gap Down
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583,000.00£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
3.1496 of 5 stars
GBX 1,580
+0.3%
GBX 2,800
+77.2%
-15.5%£678.87M£230.77M58.37734Insider Trade
News Coverage
Positive News
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500Positive News
KOO
Kooth
N/AGBX 152
flat
GBX 456.67
+200.4%
-49.6%£55.79M£50.72M14.28478

Related Companies and Tools


This page (LON:FDBK) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners